Human Investing’s National Vision EYE Stock Holding History

Human Investing’s Portfolio EYE Stock Details EYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,688	Closed	-$33K	–	325
2020 Q1	$33K	Buy	+1,688	New	+$52.6K	0.01%	175

Other funds holding EYE

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Human Investing's EYE Position: Q2 2020 in Review

Human Investing sold out of National Vision (EYE) in Q2 2020, closing a stake of 1,688 shares — an estimated $33K sold.

Human Investing first reported a position in EYE in Q1 2020 and held it in 1 quarter. The position peaked at $33K in Q1 2020. 154 funds tracked by Wall St. Rank hold EYE as of Q2 2020.

Human Investing reported no remaining National Vision position as of Q2 2020 after selling out during the quarter.
Human Investing sold 1,688 National Vision shares in Q2 2020, an estimated $33K.
Human Investing first reported a position in National Vision in Q1 2020 and held it in 1 quarter.
Human Investing's National Vision position peaked at $33K in Q1 2020.
154 funds tracked by Wall St. Rank held National Vision as of Q2 2020.

Based on Human Investing's 13F filing for Q2 2020, filed 22 Jul 2020.